For decades, it has been common practice that local governments attract investors by offering them various financial incentives mostly in the form of subsidies.

On 3 April 2024, the National Medical Products Administration ("NMPA") released the Notice on Further Strengthening the Supervision and Management of Entrusted Manufacturing...

The PRC Drugs Prohibition Law classifies "marijuana"—products from the plant Cannabis sativa that contain substantial amounts of tetrahydrocannabinol (THC)—as drugs and prohibits its use in any form

On 29 December 2023, the Standing Committee of the National People's Congress issued a major update to the current PRC Company Law. The revised PRC Company Law will enter into effect on 1 July 2024.

On 19 September 2017, the China International Economic and Trade Arbitration Commission ("CIETAC") published the Arbitration Rules of the China International Economic and Trade Arbitration Commission...

The Supreme People's Court ("SPC") of the People's Republic of China ("PRC") has recently promulgated the Interpretation on Several Issues Concerning the Application of Law to the Trial of Cases of Disputes over Punitive Damages in Food and Drugs ("Interpretation"), taking effect from August 22, 2024.

To implement the Drug Administration Law of the PRC, a draft version of the Measures for Supervision and Administration of Drug Supply was publicized in September 2019 for public opinion

The National Medical Products Administration ("NMPA") issued the Circular on the Work Relating to the Implementation of GB 9706.1-2020 and Supporting Concurrent Standards and Special Standards

Wholly foreign-invested hospitals have always been a sector under relatively strict regulation in the PRC, except for limited cases as pilots.